INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 420s ago
HOUSE PTR20s ago
SEC 13F6h ago
ROBINHOOD CHAIN6h ago
SEC FORM 4/Open-market saleVerified dataRule 10b5-1 plan

Landry Benjamin sold HCAT

General Counsel · Health Catalyst, Inc. · Common Stock

Side
SELL
Value
$72K
Shares
27.4K
Price
$2.64
Executed
Dec 5, 2025
Disclosed
Dec 9, 2025
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Dec 5 executedDec 9, 2025 disclosed

HCAT · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
21/ 100 · ROUTINE
Methodology →
  • Transaction type+6 / 20

    Open-market sale

  • Relative size+12 / 25

    $72K reported value · 21.5% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering+5 / 15

    1 other actor traded the same direction within 14 days

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • Pre-arranged plan-10

    Executed under a Rule 10b5-1 trading plan

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · HCAT

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    12
    AB
    Albert BenjaminDirector, CEO
    HCATHealth Catalyst, Inc.
    Tax withholding
    		F$59K
    35.2K sh
    		Sep 10, 2026Sep 11, 2026
    traded Sep 10, 2026
    		+1dSEC FORM 4

    Evidence

    9
    AB
    Albert BenjaminDirector, CEO
    HCATHealth Catalyst, Inc.
    Tax withholding
    		F$547
    321 sh
    		Sep 1, 2026Sep 3, 2026
    traded Sep 1, 2026
    		+2dSEC FORM 4

    Evidence

    18
    AB
    Albert BenjaminDirector, CEO
    HCATHealth Catalyst, Inc.
    Tax withholding
    		F$58K
    34.5K sh
    		Jun 10, 2026Jun 15, 2026
    traded Jun 10, 2026
    		+5dSEC FORM 4

    Evidence

    9
    AB
    Albert BenjaminDirector, CEO
    HCATHealth Catalyst, Inc.
    Tax withholding
    		F$460
    336 sh
    		Jun 1, 2026Jun 3, 2026
    traded Jun 1, 2026
    		+2dSEC FORM 4

    Evidence

    9
    AB
    Albert BenjaminDirector, CEO
    HCATHealth Catalyst, Inc.
    Grant or award
    		A—
    1,124 sh
    		Apr 29, 2026May 1, 2026
    traded Apr 29, 2026
    		+2dSEC FORM 4

    Evidence

    9
    AB
    Albert BenjaminDirector, CEO
    HCATHealth Catalyst, Inc.
    Tax withholding
    		F$417
    310 sh
    		May 1, 2026May 1, 2026
    traded May 1, 2026
    		+0dSEC FORM 4

    Evidence

    22
    AB
    Albert BenjaminDirector, CEO
    HCATHealth Catalyst, Inc.
    Tax withholding
    		F$130K
    70.5K sh
    		Mar 10, 2026Mar 13, 2026
    traded Mar 10, 2026
    		+3dSEC FORM 4

    Evidence

    15
    AB
    Albert BenjaminDirector, CEO
    HCATHealth Catalyst, Inc.
    Tax withholding
    		F$8,243
    4,966 sh
    		Mar 2, 2026Mar 5, 2026
    traded Mar 2, 2026
    		+3dSEC FORM 4

    Evidence

    15
    LB
    Landry BenjaminGeneral Counsel
    HCATHealth Catalyst, Inc.
    Tax withholding
    		F$35K
    20.8K sh
    		Mar 2, 2026Mar 5, 2026
    traded Mar 2, 2026
    		+3dSEC FORM 4

    Evidence

    21
    AB
    Albert BenjaminDirector, CEO
    HCATHealth Catalyst, Inc.
    Grant or award
    		A—
    930.0K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    AB
    Albert BenjaminDirector, CEO
    HCATHealth Catalyst, Inc.
    Grant or award
    		A—
    38.8K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    AB
    Albert BenjaminDirector, CEO
    HCATHealth Catalyst, Inc.
    Tax withholding
    		F$23K
    13.3K sh
    		Feb 26, 2026Feb 27, 2026
    traded Feb 26, 2026
    		+1dSEC FORM 4

    Evidence

    17
    LB
    Landry BenjaminGeneral Counsel
    HCATHealth Catalyst, Inc.
    Grant or award
    		A—
    289.0K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    5
    LB
    Landry BenjaminGeneral Counsel
    HCATHealth Catalyst, Inc.
    Grant or award
    		A—
    16.5K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    5
    LB
    Landry BenjaminGeneral Counsel
    HCATHealth Catalyst, Inc.
    Tax withholding
    		F$11K
    6,317 sh
    		Feb 26, 2026Feb 27, 2026
    traded Feb 26, 2026
    		+1dSEC FORM 4

    Evidence

    43
    LJ
    Larson-Green JulieDirector
    HCATHealth Catalyst, Inc.
    Open-market sale
    		SELL$128K
    48.0K sh
    		Dec 4, 2025Dec 9, 2025
    traded Dec 4, 2025
    		+5dSEC FORM 4

    Evidence

    13
    LB
    Landry BenjaminGeneral Counsel
    HCATHealth Catalyst, Inc.
    Tax withholding
    		F$42K
    14.4K sh
    		Dec 1, 2025Dec 3, 2025
    traded Dec 1, 2025
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001975281-25-000003
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Dec 5, 2025
    Published
    Dec 9, 2025
    Ingested by INSIDER
    Nov 5, 04:28 UTC
    Last re-read
    Nov 5, 04:28 UTC

    Extracted facts

    Filer
    Landry Benjamin
    Role
    General Counsel
    Transaction
    Open-market saleAs filed: “S”
    Asset
    Health Catalyst, Inc.
    Ticker
    HCAT
    Shares
    27.4K
    Price per share
    $2.64
    Value
    $72,328
    Execution date (reported)
    Dec 5, 2025
    Owned after transaction
    100.0K shares
    Rule 10b5-1 plan
    Yes, as checked by the filer
    Days from execution to publication
    4

    Calculation

    Value = shares × reported price per share

    • Shares: 27.4K
    • Price: $2.6373

    = $72,328

    What this establishes

    Landry Benjamin filed this Form 4 reporting a open-market sale of HCAT on Dec 5, 2025. It became public on Dec 9, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    General Counsel
    Landry Benjamincik:0001975281
    Issuer
    Health Catalyst, Inc.cik:0001636422

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.